Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
3 "Mi Joo Chung"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Articles
Predictors of Distant Metastasis after Radical Surgery Followed by Postoperative Radiotherapy with or without Chemotherapy for Oropharyngeal Cancer
Mi Joo Chung, Yeon Sil Kim, Ji Yoon Kim, Yun Hee Lee, Ji Hyun Jang, Jin Hyoung Kang, Ie Ryung Yoo, Youn Soo Lee
Cancer Res Treat. 2016;48(4):1167-1176.   Published online March 3, 2016
DOI: https://doi.org/10.4143/crt.2015.379
AbstractAbstract PDFPubReaderePub
Purpose
We investigated the prognostic factors for distant metastasis (DM) in patients with locally advanced oropharyngeal cancer (OPC) treated with surgery and adjuvant radiotherapy with or without concurrent chemotherapy.
Materials and Methods
Eighty-five patients treated between January 1995 and August 2014 were evaluated retrospectively. Data regarding the pathological tumour and nodal status, human papillomavirus (HPV) status, treatment characteristics, and pretreatment maximum standardized uptake value (SUVmax) of 18-fluoro-2-deoxyglucose positron emission tomography–computed tomography scan (18F-FDG PET-CT) were evaluated, and their influence on DM and survival outcomes were analyzed.
Results
Median follow-up period was 48.0 months. Recurrence was observed in 20 patients, including locoregional recurrence and DM. DM was observed in 13 patients. A multivariate analysis confirmed that the presence of lymphovascular invasion (p=0.031), lower neck lymph node (LN) involvement (p=0.006), SUVmax ≥ 9.7 (p=0.014), and tumour size ≥ 3 cm (p=0.037) significantly affected DM. HPV status was not associated with DM. Perineural invasion (p=0.048), lower neck LNinvolvement (p=0.008), SUVmax ≥ 9.7 (p=0.019), and tumour size ≥ 3 cm (p=0.033) were also significant factors for the DM-free survival rate.
Conclusion
Lower neck LN involvement, high SUVmax in pretreatment 18F-FDG PET-CT, and large tumour size were predictive factors for DM in patients of OPC.

Citations

Citations to this article as recorded by  
  • An open, multicenter, exploratory study of apatinib mesylate maintenance therapy for recurrent/metastatic head and neck squamous cell carcinoma (ChiCTR1800019375)
    Jinlong Wei, Jing Su, Jianfeng Wang, Xiaojing Jia, Qin Zhao, Weiyan Shi, Huanhuan Wang, Zhuangzhuang Zheng, Xin Jiang
    Head & Neck.2024; 46(4): 915.     CrossRef
  • The Prognostic Role of Perineural Invasion for Survival in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
    Zhuo-Ying Tao, Guang Chu, Yu-Xiong Su
    Cancers.2024; 16(14): 2514.     CrossRef
  • Management of Recurrent HPV-Positive Oropharyngeal Squamous Cell Carcinoma: a Contemporary Review
    Sam Dowthwaite, James Jackson, Marcin Dzienis, Eric Khoo, Mathew Cronin, Emily Guazzo
    Current Oncology Reports.2023; 25(5): 501.     CrossRef
  • A Mn-doped calcium phosphate nanoparticle-based multifunctional nanocarrier for targeted drug delivery and cellular MR imaging
    Chaohui Zhou, Shenglei Hou, Chusen Huang, Nengqin Jia
    Journal of Nanoparticle Research.2022;[Epub]     CrossRef
  • Importance of lymph node ratio in HPV-related oropharyngeal cancer patients treated with surgery and adjuvant treatment
    Kyu Hye Choi, Jin Ho Song, Ji Hyun Hong, Youn Soo Lee, Jin Hyoung Kang, Dong-Il Sun, Min-Sik Kim, Yeon-Sil Kim, Yifei Wang
    PLOS ONE.2022; 17(8): e0273059.     CrossRef
  • 18F-FDG PET/CT–Based Prognostic Survival Model After Surgery for Head and Neck Cancer
    Gwenaelle Creff, Franck Jegoux, Xavier Palard, Adrien Depeursinge, Ronan Abgral, Remi Marianowski, Jean-Christophe Leclere, Thomas Eugene, Olivier Malard, Renaud De Crevoisier, Anne Devillers, Joel Castelli
    Journal of Nuclear Medicine.2022; 63(9): 1378.     CrossRef
  • Risk stratification of postoperative recurrence in hypopharyngeal squamous-cell carcinoma patients with nodal metastasis
    Hanqing Lin, Tian Wang, Yu Heng, Xiaoke Zhu, Liang Zhou, Ming Zhang, Yong Shi, Pengyu Cao, Lei Tao
    Journal of Cancer Research and Clinical Oncology.2021; 147(3): 803.     CrossRef
  • A two-fold interpenetration pillar-layered metal-organic frameworks based on BODIPY for chemo-photodynamic therapy
    Yang Meng, Yingying Du, Yanxin Lin, Yu Su, Ruonan Li, Yaqing Feng, Shuxian Meng
    Dyes and Pigments.2021; 188: 109174.     CrossRef
  • Current Updates on Cancer-Causing Types of Human Papillomaviruses (HPVs) in East, Southeast, and South Asia
    Chichao Xia, Sile Li, Teng Long, Zigui Chen, Paul K. S. Chan, Siaw Shi Boon
    Cancers.2021; 13(11): 2691.     CrossRef
  • Evaluation of the Prognostic Value of FDG PET/CT Parameters for Patients With Surgically Treated Head and Neck Cancer
    Gwenaelle Creff, Anne Devillers, Adrien Depeursinge, Xavier Palard-Novello, Oscar Acosta, Franck Jegoux, Joel Castelli
    JAMA Otolaryngology–Head & Neck Surgery.2020; 146(5): 471.     CrossRef
  • Sequentially self-assembled polysaccharide-based nanocomplexes for combined chemotherapy and photodynamic therapy of breast cancer
    Yaping Wang, Ming Yang, Junmin Qian, Weijun Xu, Jinlei Wang, Guanghui Hou, Lijie Ji, Aili Suo
    Carbohydrate Polymers.2019; 203: 203.     CrossRef
  • Self-assembly of photosensitive and chemotherapeutic drugs for combined photodynamic-chemo cancer therapy with real-time tracing property
    Shengtao Wang, Jingtao Li, Zhou Ye, Jieling Li, Anhe Wang, Jing Hu, Shuo Bai, Jian Yin
    Colloids and Surfaces A: Physicochemical and Engineering Aspects.2019; 574: 44.     CrossRef
  • Patterns of recurrence in oral tongue cancer with perineural invasion
    Jennifer R. Cracchiolo, Bin Xu, Jocelyn C. Migliacci, Nora Katabi, David G. Pfister, Nancy Y. Lee, Snehal G. Patel, Ronald A. Ghossein, Richard J. Wong
    Head & Neck.2018; 40(6): 1287.     CrossRef
  • Targeted Chemo-Photodynamic Combination Platform Based on the DOX Prodrug Nanoparticles for Enhanced Cancer Therapy
    Yumin Zhang, Fan Huang, Chunhua Ren, Lijun Yang, Jianfeng Liu, Zhen Cheng, Liping Chu, Jinjian Liu
    ACS Applied Materials & Interfaces.2017; 9(15): 13016.     CrossRef
  • 10,961 View
  • 222 Download
  • 9 Web of Science
  • 14 Crossref
Close layer
Setup Error and Effectiveness of Weekly Image-Guided Radiation Therapy of TomoDirect for Early Breast Cancer
Mi Joo Chung, Guk Jin Lee, Young Jin Suh, Hyo Chun Lee, Sea-Won Lee, Songmi Jeong, Jeong Won Lee, Sung Hwan Kim, Dae Gyu Kang, Jong Hoon Lee
Cancer Res Treat. 2015;47(4):774-780.   Published online February 13, 2015
DOI: https://doi.org/10.4143/crt.2014.189
AbstractAbstract PDFPubReaderePub
Purpose
This study investigated setup error and effectiveness of weekly image-guided radiotherapy (IGRT) of TomoDirect for early breast cancer. Materials and Methods One hundred and fifty-one breasts of 147 consecutive patients who underwent breast conserving surgery followed by whole breast irradiation using TomoDirect in 2012 and 2013 were evaluated. All patients received weekly IGRT. The weekly setup errors from simulation to each treatment in reference to chest wall and surgical clips were measured. Random, systemic, and 3-dimensional setup errors were assessed. Extensive setup error was defined as 5 mm above the margin in any directions.
Results
All mean errors were within 3 mm of all directions. The mean angle of gantry shifts was 0.6°. The mean value of absolute 3-dimensional setup error was 4.67 mm. In multivariate analysis, breast size (odds ratio, 2.82; 95% confidence interval, 1.00 to 7.90) was a significant factor for extensive error. The largest significant deviation of setup error was observed in the first week of radiotherapy (p < 0.001) and the deviations gradually decreased with time. The deviation of setup error was 5.68 mm in the first week and within 5 mm after the second week. Conclusion In this study, there was a significant association between breast size and significant setup error in breast cancer patients who received TomoDirect. The largest deviation occurred in the first week of treatment. Therefore, patients with large breasts should be closely observed on every fraction and fastidious attention is required in the first fraction of IGRT.

Citations

Citations to this article as recorded by  
  • Does deformation of immobilization devices impact treatment accuracy in thoracic cancer radiotherapy?
    Lianzi Zhao, Louzheng Zhang, Yiwen Hu, Yang Zhong
    Journal of Applied Clinical Medical Physics.2025;[Epub]     CrossRef
  • AAPM Task Group Report 306: Quality control and assurance for tomotherapy: An update to Task Group Report 148
    Quan Chen, Yi Rong, Jay W. Burmeister, Edward H. Chao, Nathan A. Corradini, David S. Followill, X. Allen Li, An Liu, X. Sharon Qi, Hairong Shi, Jennifer B. Smilowitz
    Medical Physics.2023;[Epub]     CrossRef
  • Robustness of VMAT to setup errors in postmastectomy radiotherapy of left-sided breast cancer: Impact of bolus thickness
    Yipeng He, Sijia Chen, Xiang Gao, Lirong Fu, Zheng Kang, Jun Liu, Liwan Shi, Yimin Li, Akif Enes Arikan
    PLOS ONE.2023; 18(1): e0280456.     CrossRef
  • ESTRO-ACROP guideline for positioning, immobilisation and setup verification for local and loco-regional photon breast cancer irradiation
    M.E. Mast, A. Leong, S.S. Korreman, G. Lee, H. Probst, P. Scherer, Y. Tsang
    Technical Innovations & Patient Support in Radiation Oncology.2023; 28: 100219.     CrossRef
  • Critical Factors of Dose Distribution in Breast Cancer Tomotherapy With Metallic Port Breast Tissue Expander: Image Correction, Delivery Mode, and Volume Impact
    Hsing-Yi Lee, Yu-Hsiu Yen, Yu-Lun Tsai, Pei-Chih Tu, Chi-Ming Pu, Chia-Hong Lin, Louis Tak Lui, Suzun Shaw, Ching-Jung Wu, Hsin-Hua Nien
    Technology in Cancer Research & Treatment.2022;[Epub]     CrossRef
  • Factors impacting on patient setup analysis and error management during breast cancer radiotherapy
    Ioana-Claudia Costin, Loredana G. Marcu
    Critical Reviews in Oncology/Hematology.2022; 178: 103798.     CrossRef
  • Postoperative radiotherapy with intensity-modulated radiation therapy versus 3-dimensional conformal radiotherapy in early breast cancer: A randomized clinical trial of KROG 15-03
    Kyu Hye Choi, Sung Ja Ahn, Jae Uk Jeong, Mina Yu, Jin Hee Kim, Bae Kwon Jeong, Joo Hwan Lee, Sung Hwan Kim, Jong Hoon Lee
    Radiotherapy and Oncology.2021; 154: 179.     CrossRef
  • Analysis of local setup errors of sub-regions in cone-beam CT-guided post-mastectomy radiation therapy
    Jidan Zhou, Shuai Li, Chengwei Ye, Konglong Shen, An Li, Gang Chen, Xiaoyu Li, Sen Bai, Weifeng Wang, Renming Zhong
    Journal of Radiation Research.2020; 61(3): 457.     CrossRef
  • A Prospective Study to Investigate the Placement of Setup Skin Markings for Larger Breasted Women Undergoing External Beam Radiotherapy (RT) for Breast Cancer
    Chris Osam Doudoo, Neill Roberts, Emmanuel Amankwaa Frempong, Clement Edusa, Kwamena Beecham, Kofi Agyiri, Promise Ahiagbenyo, George Felix Acquah, Dominic Gadeka Eric Abakuri, Michael Mordey, Anna Maria Anim, Bismark Djan
    International Journal of Scientific Research in Science and Technology.2019; : 99.     CrossRef
  • Dosimetric Comparison of Setup Errors in Intensity Modulated Radiation Therapy with Deep Inspiration Breath Holding in Breast Cancer Radiation Therapy
    Ham Il-Sik, Cho Pyong-Kon, Jung Kang-Kyo
    Journal of Radiological Science and Technology.2019; 42(2): 137.     CrossRef
  • Setup Error Assessment and Correction in Planar kV Image- Versus Cone Beam CT Image-Guided Radiation Therapy: A Clinical Study of Early Breast Cancer Treated With External Beam Partial Breast Irradiation
    Wei Wang, Ting Yu, Min Xu, Qian Shao, Yingjie Zhang, Jianbin Li
    Technology in Cancer Research & Treatment.2019;[Epub]     CrossRef
  • A Potential Anti-Tumor Herb Bred in a Tropical Fruit: Insight into the Chemical Components and Pharmacological Effects of Momordicae Semen
    Xiao-Rong Xu, Chuan-Hong Luo, Bo Cao, Run-Chun Xu, Fang Wang, Xi-Chuan Wei, Ting Zhang, Li Han, Ding-Kun Zhang
    Molecules.2019; 24(21): 3949.     CrossRef
  • Xihuang pill promotes apoptosis of Treg cells in the tumor microenvironment in 4T1 mouse breast cancer by upregulating MEKK1/SEK1/JNK1/AP-1 pathway
    Liang Su, Yiming Jiang, Yu Xu, Xinye Li, Wenbin Gao, Chunwei Xu, Changqian Zeng, Jie Song, Wencai Weng, Wenbo Liang
    Biomedicine & Pharmacotherapy.2018; 102: 1111.     CrossRef
  • The Antitumor Effect of Xihuang Pill on Treg Cells Decreased in Tumor Microenvironment of 4T1 Breast Tumor‐Bearing Mice by PI3K/AKT~AP‐1 Signaling Pathway
    Xin-ye Li, Liang Su, Yi-ming Jiang, Wen-bin Gao, Chun-wei Xu, Chang-qian Zeng, Jie Song, Yu Xu, Wen-cai Weng, Wen-bo Liang, Jian-Li Gao
    Evidence-Based Complementary and Alternative Medicine.2018;[Epub]     CrossRef
  • Setup errors and effectiveness of Optical Laser 3D Surface imaging system (Sentinel) in postoperative radiotherapy of breast cancer
    Xiaobo Wei, Mengjiao Liu, Yun Ding, Qilin Li, Changhai Cheng, Xian Zong, Wenming Yin, Jie Chen, Wendong Gu
    Scientific Reports.2018;[Epub]     CrossRef
  • Applying human factors engineering methods for hazard identification and mitigation in the radiotherapy process
    Mariana Bernardes, Clarissa Trzesniak, Patricia Trbovich, Carlos Henrique Pereira Mello
    Safety Science.2018; 109: 270.     CrossRef
  • Compared with intensity‐modulated radiotherapy, image‐guided radiotherapy reduces severity of acute radiation‐induced skin toxicity during radiotherapy in patients with breast cancer
    Jang‐Chun Lin, Jo‐Ting Tsai, Yu‐Ching Chou, Ming‐Hsien Li, Wei‐Hsiu Liu
    Cancer Medicine.2018; 7(8): 3622.     CrossRef
  • A topology-based method to mitigate the dosimetric uncertainty caused by the positional variation of the boost volume in breast conservative radiotherapy
    Peng-Yi Lee, Chih-Yuan Lin, Shang-Wen Chen, Chun-Ru Chien, Chun-Nan Chu, Hsiu-Ting Hsu, Ji-An Liang, Ying-Jun Lin, An-Cheng Shiau
    Radiation Oncology.2017;[Epub]     CrossRef
  • Setup deviations for whole-breast radiotherapy with TomoDirect: A comparison of weekly and biweekly image-guided protocols
    Jae Hong Jung, Joo-Young Jung, Sun Hyun Bae, Seong Kwon Moon, Kwang Hwan Cho
    Journal of the Korean Physical Society.2016; 69(7): 1247.     CrossRef
  • Displacement of Surgical Clips during Postoperative Radiotherapy in Breast Cancer Patients Who Received Breast-Conserving Surgery
    SooYoon Sung, Joo Hwan Lee, Jong Hoon Lee, Sung Hwan Kim, Yoo-Kang Kwak, Sea-Won Lee, Ye Won Jeon, Young Jin Suh
    Journal of Breast Cancer.2016; 19(4): 417.     CrossRef
  • Review on the Applications and Molecular Mechanisms ofXihuangPill in Tumor Treatment
    Qiujun Guo, Jinyin Lin, Rui Liu, Yebo Gao, Shulin He, Xinyao Xu, Baojin Hua, Conghuang Li, Wei Hou, Honggang Zheng, Yanju Bao
    Evidence-Based Complementary and Alternative Medicine.2015; 2015: 1.     CrossRef
  • 15,153 View
  • 179 Download
  • 21 Web of Science
  • 21 Crossref
Close layer
Postoperative Radiotherapy Alone Versus Chemoradiotherapy in Stage I-II Endometrial Carcinoma: An Investigational and Propensity Score Matching Analysis
Jong Hoon Lee, Hyo Chun Lee, Sung Hwan Kim, Mi Joo Chung, Song Mi Jeong, Sung Jong Lee, Joo Hee Yoon, Dong Choon Park
Cancer Res Treat. 2015;47(2):298-305.   Published online September 15, 2014
DOI: https://doi.org/10.4143/crt.2014.038
AbstractAbstract PDFPubReaderePub
Purpose
The purpose of this study was to compare the results of postoperative adjuvant radiotherapy (RT) and concurrent chemoradiotherapy (CRT) in stage I-II endometrial carcinoma. Materials and Methods We analyzed a total of 64 patients with surgically staged I-II endometrial carcinoma who were treated with postoperative adjuvant RT or concurrent CRT between March 1999 and July 2013. Thirty-two patients who received postoperative RT alone were matched with those who received postoperative CRT (n=32) in accordance to age, stage, and tumor histology. Overall survival and relapse-free survival, as well as toxicity of the RT and CRT arms were evaluated and compared. Results The 5-year overall survival rate was 90.0% for the RT arm and 91.6% for the CRT arm. There was no significant difference in overall survival between the two treatment arms (p=0.798). The 5-year relapse-free survival rate was 87.2% in the RT arm and 88.0% in the CRT arm. Again, no significant difference in relapse-free survival was seen between the two arms (p=0.913). In a multivariate analysis, tumor histology was an independent prognostic factor for relapse-free survival (hazard ratio, 3.67; 95% of CI, 2.34 to 7.65; p=0.045). Acute grade 3 or 4 hematologic toxicities in the CRT arm were significantly higher than in the RT alone arm (6.2% vs. 31.2%, p=0.010). Conclusion Adjuvant pelvic concurrent chemoradioherapy did not show superior results in overall survival and relapse-free survival compared to RT alone in stage I-II endometrial carcinoma.

Citations

Citations to this article as recorded by  
  • Impacts of Postoperative Adjuvant Therapies on the Survival of Women with High-Risk Early-Stage Endometrial Cancer: A Cohort Study
    Hee Joong Lee, Banghyun Lee
    Cancers.2025; 17(2): 187.     CrossRef
  • Adjuvant Therapy Use and Survival in Stage II Endometrial Cancer
    Nataniel H. Lester-Coll, Melissa R. Young, Henry S. Park, Elena S. Ratner, Babak Litkouhi, Shari Damast
    International Journal of Gynecological Cancer.2017; 27(9): 1904.     CrossRef
  • 13,269 View
  • 108 Download
  • 4 Web of Science
  • 2 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP